Definitions of Urinary Tract Infection in Current Research: A Systematic Review
暂无分享,去创建一个
S. Geerlings | S. Conroy | L. Mody | J. Caterino | C. van Nieuwkoop | L. Visser | F. Wagenlehner | C. Schneeberger | B. Köves | Manu P Bilsen | T. Platteel | M. Lambregts | Rosa M H Jongeneel
[1] M. Numans,et al. Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] R. Pickard,et al. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. , 2022, Health technology assessment.
[3] P. Eckburg,et al. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection. , 2022, The New England journal of medicine.
[4] Julia Sapozhnikov,et al. Intravenous to Oral Antibiotics Versus Intravenous Antibiotics: A Step-Up or a Step-Down for Extended Spectrum Beta-Lactamase Producing Urinary Tract Infections Without Concomitant Bacteremia? , 2022, International journal of antimicrobial agents.
[5] J. Rodríguez-Baño,et al. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections , 2022, JAMA network open.
[6] Islam M. Ghazi,et al. Is Cefoxitin a Carbapenem Sparing Agent in the Management of Urinary Tract Infections Caused by ESBL Producing Enterobacterales? , 2021, Hospital pharmacy.
[7] S. REDDY B,et al. ASSESSMENT OF EFFICACY AND SAFETY OF ORAL FOSFOMYCIN SINGLE DOSE IN UNCOMPLICATED URINARY TRACT INFECTION AT A TERTIARY CARE HOSPITAL IN SOUTH INDIA , 2021, Asian Journal of Pharmaceutical and Clinical Research.
[8] S. Butler-Wu,et al. Fosfomycin versus Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study , 2021, Open Forum Infectious Diseases.
[9] C. Giske,et al. The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden. , 2021, The Lancet. Infectious diseases.
[10] A. Neisius,et al. Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: a comparative single-centre study , 2021, International Urology and Nephrology.
[11] J. R. Johnson,et al. Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial. , 2021, JAMA.
[12] P. Sand,et al. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial , 2021, International Urogynecology Journal.
[13] T. Friede,et al. Herbal treatment with Uva Ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[15] H. Stammer,et al. Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study , 2021, Archives of Gynecology and Obstetrics.
[16] D. Guyonnet,et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial , 2021, BMC Urology.
[17] N. Chen,et al. A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection , 2020, Annals of medicine.
[18] K. Cunha,et al. Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment Outcomes , 2020, Research and reports in urology.
[19] E. Pérez-Nadales,et al. Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project) , 2020, Transplant infectious disease : an official journal of the Transplantation Society.
[20] S. Kohno,et al. The safety and efficacy of relebactam/imipenem/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study. , 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[21] M. Arpi,et al. Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus. , 2020, The Journal of antimicrobial chemotherapy.
[22] Sara Abolghasemi,et al. Levofloxacin versus ceftriaxone for treatment of acute pyelonephritis in Iranian adults. , 2020, Infectious disorders drug targets.
[23] P. Popescu,et al. Combination of cranberry extract and D-mannose - possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: Results of a pilot study. , 2020, Experimental and therapeutic medicine.
[24] A. Barth,et al. Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis) , 2020, Antimicrobial Agents and Chemotherapy.
[25] A. Farsinezhad,et al. The therapeutic effect of intravesical instillation of platelet rich plasma on recurrent bacterial cystitis in women: a randomized clinical trial. , 2019, Urology journal.
[26] S. Cosgrove,et al. Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms? , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] R. Isaacs,et al. Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis , 2019, Antimicrobial Agents and Chemotherapy.
[28] Hong-Chiang Chang,et al. The efficacy of pentosan polysulfate monotherapy for preventing recurrent urinary tract infections in women: A multicenter open-label randomized controlled trial. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.
[29] R. Lepeule,et al. Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase–producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis , 2019, European Journal of Clinical Microbiology & Infectious Diseases.
[30] Y. Trivedi,et al. Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study , 2019, Expert review of anti-infective therapy.
[31] J. Li,et al. Colistin in the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical. , 2019, The Journal of infection.
[32] A. Payasi,et al. Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial , 2019, Open forum infectious diseases.
[33] T. Benfield,et al. Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial☆ , 2019, EClinicalMedicine.
[34] E. Lukacz,et al. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. , 2019, Female pelvic medicine & reconstructive surgery.
[35] C. van Nieuwkoop,et al. Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant Bacteria , 2019, The Journal of urology.
[36] M. Bonten,et al. Fosfomycin-Trometamol for Urinary Tract Infections in Kidney Transplant Recipients. , 2019, Transplantation.
[37] G. Karsenty,et al. A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis , 2019, Urologia Internationalis.
[38] A. Edu,et al. Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults , 2019, Urologia Internationalis.
[39] S. Bai,et al. Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study , 2019, Antimicrobial Agents and Chemotherapy.
[40] L. Rice,et al. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] L. Miller,et al. Once‐Daily Plazomicin for Complicated Urinary Tract Infections , 2019, The New England journal of medicine.
[42] M. Yasuda,et al. The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. , 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[43] T. Tängdén,et al. Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men , 2019, PloS one.
[44] R. Parsons,et al. The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study , 2019, PloS one.
[45] S. Nimitvilai,et al. Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial , 2019, Infection and drug resistance.
[46] J. Pouliot,et al. Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae , 2018, Hospital pharmacy.
[47] A. Shahat,et al. Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study , 2018, World Journal of Urology.
[48] James R. Johnson. Definitions of Complicated Urinary Tract Infection and Pyelonephritis. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] Betsy Foxman,et al. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. , 2014, Infectious disease clinics of North America.
[50] A. Stapleton,et al. Voided midstream urine culture and acute cystitis in premenopausal women. , 2013, The New England journal of medicine.
[51] Philip Smith,et al. Surveillance Definitions of Infections in Long-Term Care Facilities: Revisiting the McGeer Criteria , 2012, Infection Control & Hospital Epidemiology.
[52] B. Trautner,et al. Urinary Tract Infection , 2012, Annals of Internal Medicine.
[53] K. Naber,et al. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. , 2011, International journal of antimicrobial agents.
[54] G. Kaspers,et al. Pyuria is absent during urinary tract infections in neutropenic patients , 2011, Pediatric blood & cancer.
[55] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] D. van den Broek,et al. Benefits of the iQ200 automated urine microscopy analyser in routine urinalysis , 2008, Clinical chemistry and laboratory medicine.
[57] M. André,et al. Asymptomatic bacteriuria in the elderly: High prevalence and high turnover of strains , 2008, Scandinavian journal of infectious diseases.
[58] Richard Colgan,et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] Michael L Wilson,et al. Laboratory diagnosis of urinary tract infections in adult patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] Sanjay Saint,et al. Does this woman have an acute uncomplicated urinary tract infection? , 2002, JAMA.
[61] J. Schnelle,et al. Accuracy of Rapid Urine Screening Tests Among Incontinent Nursing Home Residents with Asymptomatic Bacteriuria , 1995, Journal of the American Geriatrics Society.
[62] K. Holmes,et al. Diagnosis of coliform infection in acutely dysuric women. , 1982, The New England journal of medicine.
[63] OUP accepted manuscript , 2021, Clinical Infectious Diseases.
[64] Sami M. Aloush,et al. Effectiveness of antibiotics versus ibuprofen in relieving symptoms of nosocomial urinary tract infection: A comparative study , 2019, Journal of the American Association of Nurse Practitioners.
[65] ,et al. NHG-Standaard Urineweginfecties , 2005 .